TRAF2 mediates sensitivity to immunomodulatory drugs via NF-κB and ERK signaling in myeloma cells

被引：0
|
作者：
Liu, Jiye [1 ]
Hideshima, Teru [1 ]
Xing, Lijie [1 ]
Wang, Su [2 ]
Zhou, Wenrong [3 ]
Ogiya, Daisuke [1 ]
Wen, Kenneth [1 ]
Tai, Yu-Tzu [1 ]
Cang, Yong [4 ]
Anderson, Kenneth C. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] WuXi AppTec Grp, Shanghai, Peoples R China
[4] ShanghaiTech Univ, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-642
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
642
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TRAF2 Mediates Sensitivity to Immunomodulatory Drugs in the Bone Marrow Microenvironment
    Liu, Jiye
    Hideshima, Teru
    Xing, Lijie
    Wang, Su
    Ogiya, Daisuke
    Samur, Mehmet K.
    Munshi, Nikhil C.
    Richardson, Paul G.
    Wen, Kenneth
    Tai, Yu-Tzu
    Cang, Yong
    Anderson, Kenneth
    BLOOD, 2020, 136
  • [2] FLASH coordinates NF-κB activity via TRAF2
    Choi, YH
    Kim, KB
    Kim, HH
    Hong, GS
    Kwon, YK
    Chung, CW
    Park, YM
    Shen, ZJ
    Kim, BJ
    Lee, SY
    Jung, YK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) : 25073 - 25077
  • [3] Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
    Li Yang
    Jing Chen
    Xiaoyan Han
    Enfan Zhang
    Xi Huang
    Xing Guo
    Qingxiao Chen
    Wenjun Wu
    Gaofeng Zheng
    Donghua He
    Yi Zhao
    Yang Yang
    Jingsong He
    Zhen Cai
    Protein & Cell, 2018, 9 (09) : 770 - 784
  • [4] Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
    Yang, Li
    Chen, Jing
    Han, Xiaoyan
    Zhang, Enfan
    Huang, Xi
    Guo, Xing
    Chen, Qingxiao
    Wu, Wenjun
    Zheng, Gaofeng
    He, Donghua
    Zhao, Yi
    Yang, Yang
    He, Jingsong
    Cai, Zhen
    PROTEIN & CELL, 2018, 9 (09) : 770 - 784
  • [5] Scutellarein protects against cardiac hypertrophy via suppressing TRAF2/NF-κB signaling pathway
    Xiujuan Shi
    Yongjia Hu
    Yuxiong Jiang
    Jiawen Wu
    Chen Zhang
    Jieping Zhang
    Shengyu Wu
    Yingshi Wu
    Weibing Dong
    Jue Li
    Molecular Biology Reports, 2022, 49 : 2085 - 2095
  • [6] Scutellarein protects against cardiac hypertrophy via suppressing TRAF2/NF-κB signaling pathway
    Shi, Xiujuan
    Hu, Yongjia
    Jiang, Yuxiong
    Wu, Jiawen
    Zhang, Chen
    Zhang, Jieping
    Wu, Shengyu
    Wu, Yingshi
    Dong, Weibing
    Li, Jue
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (03) : 2085 - 2095
  • [7] Diverse roles for TRAF2 and TRAF3 in NF-κB pathways
    Gardam, S
    Grech, AP
    Brink, RA
    TISSUE ANTIGENS, 2005, 66 (05): : 424 - 424
  • [8] TRAF2 is an NF-κB-activating oncogene in epithelial cancers
    R R Shen
    A Y Zhou
    E Kim
    J T O'Connell
    D Hagerstrand
    R Beroukhim
    W C Hahn
    Oncogene, 2015, 34 : 209 - 216
  • [9] TRAF2 is an NF-κB-activating oncogene in epithelial cancers
    Shen, R. R.
    Zhou, A. Y.
    Kim, E.
    O'Connell, J. T.
    Hagerstrand, D.
    Beroukhim, R.
    Hahn, W. C.
    ONCOGENE, 2015, 34 (02) : 209 - 216
  • [10] TRAF2 differentially regulates the canonical and noncanonical pathways of NF-κB activation in mature B cells
    Grech, AP
    Amesbury, M
    Chan, T
    Gardam, S
    Basten, A
    Brink, R
    IMMUNITY, 2004, 21 (05) : 629 - 642
12345